MariMed, Inc. (MRMD)
0.0634
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
MariMed EPS Diluted (Quarterly) : -0.009 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.009 |
| March 31, 2026 | -0.0095 |
| December 31, 2025 | -0.0117 |
| September 30, 2025 | -0.0075 |
| June 30, 2025 | -0.0036 |
| March 31, 2025 | -0.0144 |
| December 31, 2024 | -0.0217 |
| September 30, 2024 | -0.0027 |
| June 30, 2024 | -0.0044 |
| March 31, 2024 | -0.0035 |
| December 31, 2023 | -0.027 |
| September 30, 2023 | -0.0114 |
| June 30, 2023 | -0.0026 |
| March 31, 2023 | -0.0019 |
| December 31, 2022 | 0.0124 |
| September 30, 2022 | 0.0071 |
| June 30, 2022 | 0.0048 |
| March 31, 2022 | 0.0111 |
| December 31, 2021 | -0.0195 |
| September 30, 2021 | 0.0053 |
| June 30, 2021 | 0.0202 |
| March 31, 2021 | 0.0124 |
| December 31, 2020 | 0.0131 |
| September 30, 2020 | 0.0048 |
| June 30, 2020 | -0.0049 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0105 |
| December 31, 2019 | -0.3434 |
| September 30, 2019 | -0.034 |
| June 30, 2019 | 0.0201 |
| March 31, 2019 | -0.0001 |
| December 31, 2018 | 0.0229 |
| September 30, 2018 | -0.0178 |
| June 30, 2018 | -0.0025 |
| March 31, 2018 | -0.0106 |
| December 31, 2017 | -0.0074 |
| September 30, 2017 | -0.0024 |
| June 30, 2017 | 0.0083 |
| March 31, 2017 | -0.0005 |
| December 31, 2016 | 0.0002 |
| September 30, 2016 | -0.001 |
| June 30, 2016 | -0.0009 |
| March 31, 2016 | -0.0031 |
| December 31, 2015 | -0.02 |
| September 30, 2015 | -0.0037 |
| June 30, 2015 | -0.01 |
| March 31, 2015 | -0.01 |
| December 31, 2014 | -0.11 |
| September 30, 2014 | -0.11 |
| June 30, 2014 | -0.0039 |
| March 31, 2014 | -0.0042 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Omeros Corp. | 0.1476 |
| Talphera, Inc. | -0.0571 |
| Hyperion DeFi, Inc. | 0.9232 |
| Atea Pharmaceuticals, Inc. | -0.4114 |
| Cencora, Inc. | 3.937 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.571M |
| Revenue (Quarterly) | 41.92M |
| Total Expenses (Quarterly) | 45.51M |
| Enterprise Value | 112.68M |
| Gross Profit Margin (Quarterly) | 20.87% |
| Profit Margin (Quarterly) | -8.52% |
| Earnings Yield | -59.51% |
| Normalized Earnings Yield | -59.98 |